Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation

By                    

International Journal of Oncology, Vol. 42, Iss. 6, 2013-01 ,pp. : 2094-2102

Spandidos Publications

Access to resources Recommend Favorite

Combined Treatment with Epimedium koreanum Nakai Extract and Gefitinib Overcomes Drug Resistance Caused by T790M Mutation in Non-Small Cell Lung Cancer Cells

By Song Jie   Zhong Rongling   Huang Houcai   Zhang Zhenhai   Ding Dongmei   Yan Hongmei   Sun E   Jia Xiaobin  

Nutrition and Cancer, Vol. 66, Iss. 4, 2014-05 ,pp. : 682-689

Routledge Ltd

Access to resources Recommend Favorite

Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds

By Huang Yu   Chen Yu   Mei Qin   Chen Yuan   Yu Shiying   Xia Shu  

Oncology Reports, Vol. 29, Iss. 6, 2013-06 ,pp. : 2486-2492

Spandidos Publications

Access to resources Recommend Favorite

Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFRT790M mutant lung cancer

By          

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2063-2066

Spandidos Publications

Access to resources Recommend Favorite

Polymorphisms in intron 1 of the EGFR gene in nonsmall cell lung cancer patients

By                              

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-01 ,pp. : 785-789

Spandidos Publications

Access to resources Recommend Favorite